The biomarkers scoring 17 or higher in the TASC-T score, namely, MMP9, CLDN18, TNC, CA9, and EGFR, were selected for in-depth analysis of their potential as theranostic biomarkers in CCA. This evidence concerns the gene CLDN18 and cholangiocarcinoma.